Pavlos Msaouel

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 47 papers. Top paper: “Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial”.

Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial

The Lancet Oncology(2021)10.1016/s1470-2045(21)00528-3

N/A

6.1DataRank · unranked

167 citations

Pavlos Msaouel, Kieko Hara, Haesun Choi, Venus Le, Amishi Y Shah +13 more

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer

Nature Communications(2024)10.1038/s41467-024-45132-2

N/A

0.988DataRank · unranked

35 citations

Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey E. Dobrolecki +19 more

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

Nature Biotechnology(2022)10.1038/s41587-022-01342-x

N/A

0.652DataRank · unranked

76 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Yaoyi Dai, Shuai Guo +35 more

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

British Journal of Urology(2021)10.1111/bju.15324

N/A

0.505DataRank · unranked

28 citations

Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky +41 more

Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial

Nature Communications(2025)10.1038/s41467-024-55642-8

N/A

0.406DataRank · unranked

12 citations

Herbert Yu, Ying Yuan, Jianfeng Chen, Xinmiao Yan, Menuka Karki +22 more

Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0751

N/A

0.373DataRank · unranked

11 citations

Andrew W. Hahn, Pavlos Msaouel, Alexander Andreev-Drakhlin, Funda Meric‐Bernstam, Aung Naing +17 more

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

European Urology Oncology(2024)10.1016/j.euo.2023.12.001

N/A

0.360DataRank · unranked

10 citations

Randy F. Sweis, Manojkumar Bupathi, Elisabeth Heath, Oscar B. Goodman, Christopher J. Hoimes +19 more

Association of differential censoring with survival and suboptimal control arms among oncology clinical trials

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae028

N/A

0.360DataRank · unranked

10 citations

Timothy A. Lin, Dor Reuven Dabush, Zachary R. McCaw, Alex Koong, Christine Lin +19 more

Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation

British Journal of Urology(2021)10.1111/bju.15541

N/A

0DataRank · unranked

33 citations

Aradhana M. Venkatesan, Pavlos Msaouel, Amol J. Ghia, Jing Li, D.N. Yeboa +13 more

A cytoskeletal function for PBRM1 reading methylated microtubules

Science Advances(2021)10.1126/sciadv.abf2866

N/A

0DataRank · unranked

31 citations

Rahul Jangid, Ramakrishnan Anish, Riyad N. H. Seervai, Jean‐Philippe Bertocchio, Takashi Hotta +16 more

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies

The Oncologist(2021)10.1002/onco.13770

N/A

0DataRank · unranked

37 citations

Tharakeswara Bathala, Andrew W. Hahn, Lianchun Xiao, Munevver Duran, Jeremy A. Ross +6 more

Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.07.004

N/A

0DataRank · unranked

2 citations

Andrew W. Hahn, Pavlos Msaouel, Funda Meric‐Bernstam, Nathaniel R. Wilson, Aung Naing +18 more

Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

Research Square(2021)10.21203/rs.3.rs-600171/v1

N/A

0DataRank · unranked

2 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Matthew D. Montierth, Shuai Guo +32 more

High-intensity exercise is a risk factor for renal medullary carcinoma in individuals with sickle cell trait

medRxiv(2021)10.1101/2021.02.23.21252313

N/A

0DataRank · unranked

0 citations

Melinda Soeung, Luigi Perelli, Eleonora Dondossola, Devaki Shilpa Surasi, Durga Nand Tripathi +20 more

A Cytoskeletal Function for PBRM1 Reading Methylated Microtubules

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.21.053942

N/A

0DataRank · unranked

2 citations

Rahul Jangid, Riyad N. H. Seervai, Jean‐Philippe Bertocchio, Takashi Hotta, Pavlos Msaouel +13 more

A Causal Framework for Making Individualized Treatment Decisions in Oncology

Cancers(2022)10.3390/cancers14163923

N/A

0DataRank · unranked

37 citations

Juhee Lee, José A. Karam, Peter F. Thall, Pavlos Msaouel

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.898811

N/A

0DataRank · unranked

15 citations

Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel +2 more

Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma

Nature Communications(2023)10.1038/s41467-023-38342-7

N/A

0DataRank · unranked

49 citations

Pavlos Msaouel, Cara Haymaker, Surena F. Matin, Matthew T. Campbell, Amado J. Zurita +17 more

Renal Cell Carcinoma of Variant Histology

Hematology/Oncology Clinics of North America(2023)10.1016/j.hoc.2023.04.019

N/A

0DataRank · unranked

48 citations

Giannicola Genovese, Nizar M. Tannir, Pavlos Msaouel

Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin–unresponsive Non–muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes

European Urology Open Science(2023)10.1016/j.euros.2023.04.013

N/A

0DataRank · unranked

22 citations

Valentina Grajales, Roberto Contieri, Patrick J. Hensley, Kelly K. Bree, Pavlos Msaouel +6 more

Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2

Current Oncology(2023)10.3390/curroncol30030255

N/A

0DataRank · unranked

13 citations

Whitney Throckmorton, Racheal Bingham, Pavlos Msaouel, Giannicola Genovese, John M. Slopis +4 more

Novel Clinical Trial Designs with Dose Optimization to Improve Long-term Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2222

N/A

0DataRank · unranked

8 citations

Yong Zang, Andrew Chapple, Ying Yuan, Ruitao Lin, David Marín +2 more

Risk–benefit trade-offs and precision utilities in phase I-II clinical trials

Clinical Trials(2023)10.1177/17407745231214750

N/A

0DataRank · unranked

3 citations

Juhee Lee, Peter F. Thall, Pavlos Msaouel

Interpreting Randomized Controlled Trials

Preprints.org(2023)10.20944/preprints202309.0093.v1

N/A

0DataRank · unranked

2 citations

Juhee Lee, Peter F. Thall, Pavlos Msaouel

Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.30.306795

N/A

0DataRank · unranked

5 citations

Jennifer Wang, Shuangxi Ji, Yang Peng, Matthew D. Montierth, Shuai Guo +32 more

Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients

European Urology Oncology(2024)10.1016/j.euo.2024.07.002

N/A

0DataRank · unranked

22 citations

Panayiotis Kontoyiannis, Andrew W. Hahn, Zita Dubauskas Lim, Priya Rao, Jessica P Cheng +8 more

Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials

BMJ Oncology(2024)10.1136/bmjonc-2024-000322

N/A

0DataRank · unranked

19 citations

Pavlos Msaouel, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy, Esther J. Beck +9 more

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma

Cancer Cell(2020)10.1016/j.ccell.2020.04.002

N/A

0DataRank · unranked

143 citations

Gabriel G. Malouf, Xiaoping Su, Hui Yao, Durga Nand Tripathi, Melinda Soeung +35 more

Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder

ESMO Open(2024)10.1016/j.esmoop.2024.103964

N/A

0DataRank · unranked

7 citations

Andrew M. Fang, Mohammad Jad Moussa, Hyunsoo Hwang, Nathaniel R. Wilson, Matthew T. Campbell +9 more

Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report

JCO Precision Oncology(2024)10.1200/po.24.00188

N/A

0DataRank · unranked

5 citations

Christopher J. Ricketts, Cathy D. Vocke, Dionna Gamble, Daniel R. Crooks, Ye Yang +7 more

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.022

N/A

0DataRank · unranked

5 citations

Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albigès, Kathryn E. Beckermann +19 more

Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.05.033

N/A

0DataRank · unranked

3 citations

Timothy A. Lin, Zachary R. McCaw, Esther J. Beck, Ramez Kouzy, Joseph Abi Jaoude +10 more

Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae318

N/A

0DataRank · unranked

2 citations

Alexander D. Sherry, Andrew Arifin, Gabrielle S. Kupferman, Ramez Kouzy, Joseph Abi Jaoude +8 more

Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials

The Oncologist(2024)10.1093/oncolo/oyae067

N/A

0DataRank · unranked

1 citations

Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Timothy A. Lin, Cullen M. Taniguchi +4 more

Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials

medRxiv(2024)10.1101/2024.07.23.24310891

N/A

0DataRank · unranked

3 citations

Pavlos Msaouel, Gabrielle S. Kupferman, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy +12 more

Sickle cell disease induces chromatin introversion and ferroptosis in CD8+ T cells to suppress anti-tumor immunity

Immunity(2025)10.1016/j.immuni.2025.04.020

N/A

0DataRank · unranked

18 citations

Benxia Hu, Yalan Deng, Melinda Soeung, Jun Yao, Lanxin Bei +27 more

Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values

Cancer Treatment and Research Communications(2020)10.1016/j.ctarc.2020.100166

N/A

0DataRank · unranked

32 citations

Giannicola Genovese, Nizar M. Tannir, Pavlos Msaouel, Jacob J. Adashek

CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3324

N/A

0DataRank · unranked

7 citations

Menuka Karki, Kyle A. Blum, Jean‐Philippe Bertocchio, Rong He, Durga Nand Tripathi +17 more

Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase–Deficient Renal Cell Carcinoma

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0703

N/A

0DataRank · unranked

5 citations

Manuel Ozambela, Menuka Karki, Rong He, Pankaj Kumar Chauhan, Pedro I. Pesquera +17 more

Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102423

N/A

0DataRank · unranked

3 citations

Nizar M. Tannir, Funda Meric-Bernstam, Jennifer King, Martin H. Voss, Jessica P Cheng +27 more

Survival-inferred fragility of statistical significance in phase III oncology trials

npj Precision Oncology(2025)10.1038/s41698-025-01024-2

N/A

0DataRank · unranked

1 citations

Yufei Liu, Pavlos Msaouel, Timothy A. Lin, Alex Koong, Christine Lin +12 more

Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta‐Epidemiological Analysis

Cancer Medicine(2025)10.1002/cam4.71097

N/A

0DataRank · unranked

1 citations

Pavlos Msaouel, Avital M. Miller, Ramez Kouzy, Timothy A. Lin, Joseph Abi Jaoude +3 more

Reproducibility of statistically significant phase III oncology trials: An In Silico meta-epidemiological analysis

European Journal of Cancer(2025)10.1016/j.ejca.2025.115596

N/A

0DataRank · unranked

1 citations

Pavlos Msaouel, Avital M. Miller, Timothy A. Lin, Joseph Abi Jaoude, Ramez Kouzy +7 more

Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials

medRxiv(2025)10.1101/2025.01.11.25320398

N/A

0DataRank · unranked

0 citations

Yufei Liu, Pavlos Msaouel, Timothy A. Lin, Alex Koong, Christine Lin +12 more

Precision generalized phase I-II designs

Biometrics(2025)10.1093/biomtc/ujaf043

N/A

0DataRank · unranked

0 citations

Peter F. Thall, Ying Yuan, Juhee Lee, Pavlos Msaouel, Yong Zang +1 more

Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study

UNC Libraries(2025)10.17615/3115-aq59

N/A

0DataRank · unranked

0 citations

Esther J. Beck, Alexander D. Sherry, Avital M. Miller, Pavlos Msaouel, Ramez Kouzy +8 more

Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.08.007

N/A

0DataRank · unranked

36 citations

Andrew James Wiele, Devaki Shilpa Surasi, Priya Rao, Kanishka Sircar, Pheroze Tamboli +7 more